DNA SIBLING TEST (THREE SIBLINGS)

Test Name

DNA SIBLING TEST (THREE SIBLINGS)

Aliases

SIBLING DNA TEST (THREE SIBLINGS)

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

KINSHIP TESTING

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

3

TAT Units

WEEKS

Test Requirements

For EACH alleged sibling: Passport photo, ID copy (birth certificate in case of minors) & signed consent form. Consent, passport photo and ID copy of a parent is mandatory where the alleged sibling is a minor. Not intended for medicolegal purposes which requires a court order. EDTA whole blood sample of each person tested with appropriate labeling.

Clinical Utility

Testing the relationship between alleged siblings to assess if they are biologically related as siblings i.e. full siblings, half siblings or unrelated. Sibling tests can also be used to provide reliable parentage testing when one parent is deceased or unavailable. If parent(s) are available for testing, the DNA paternity or maternity test is preferred over the DNA sibling test. Adding a known parent’s DNA sample improves accuracy by eliminating genetic material from one side of the family.

Last Review

26th Feb 2026

DNA SIBLING TEST (TWO SIBLINGS)

Test Name

DNA SIBLING TEST (TWO SIBLINGS)

Aliases

SIBLING DNA TEST (TWO SIBLINGS)

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

KINSHIP TESTING

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

3

TAT Units

WEEKS

Test Requirements

For EACH alleged sibling: Passport photo, ID copy (birth certificate in case of minors) & signed consent form. Consent, passport photo and ID copy of a parent is mandatory where the alleged sibling is a minor. Not intended for medicolegal purposes which requires a court order. EDTA whole blood sample of each person tested with appropriate labeling.

Clinical Utility

Testing the relationship between alleged siblings to assess if they are biologically related as siblings i.e. full siblings, half siblings or unrelated. Sibling tests can also be used to provide reliable parentage testing when one parent is deceased or unavailable. If parent(s) are available for testing, the DNA paternity or maternity test is preferred over the DNA sibling test. Adding a known parent’s DNA sample improves accuracy by eliminating genetic material from one side of the family.

Last Review

26th Feb 2026

NRAS EXON 1 AND 2 MUTATION

Test Name

NRAS EXON 1 AND 2 MUTATION

Aliases

-

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

ONCOLOGY

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

10

TAT Units

DAYS

Test Requirements

Tumor containing FFPE block (>10% of tumor). Tumor-containing tissue was fixed in 10% neutral buffered formalin for a duration of 6 to 72 hours. If tissue is provided, then tissue processing and FFPE block-making charges will be applicable. Clinical history and histopathology report are required.

Clinical Utility

NRAS mutations (exons 1 and 2, codons 12, 13, and 18) are clinically relevant across several cancers/ malignancies. 1. In colorectal cancer, mutation status must be confirmed before initiating anti-EGFR therapy (e.g. cetuximab, panitumumab). Mutations predict non-response/ resistance to anti-EGFR therapies. 2. In melanoma, NRAS mutations (~15–20% of cases) help guide MEK inhibitor therapy eligibility. 3. In haematological malignancies (AML, CMML), they carry prognostic value. Testing therefore drives targeted therapy decision-making, prevents exposure to ineffective treatments, and supports prognostic stratification.

Last Review

26th Feb 2026

PML::RARA, t(15; 17)(q22; q12), QUANTITATIVE PCR

Test Name

PML::RARA, t(15; 17)(q22; q12), QUANTITATIVE PCR

Aliases

PML-RARA TRANSCRIPT DETECTION, QUANTITATIVE

Abbreviations

PML-RARA QUANTITATIVE TRANSCRIPT DETECTION, PML/RARA RT-QPCR, T(15;17) QPCR

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

ONCOLOGY

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

7

TAT Units

DAYS

Test Requirements

Whole blood or bone marrow in EDTA. Prompt delivery. Time sensitive - notify central lab in advance.

Clinical Utility

Promyelocytic leukemia/retinoic acid receptor alpha fusion transcript is a tumor marker for the diagnosis and monitoring of acute promyelocytic leukemia (APML).

Last Review

26th Feb 2026

KARYOTYPING, PRODUCTS OF CONCEPTION (POCs)/ STILLBIRTH

Test Name

KARYOTYPING, PRODUCTS OF CONCEPTION (POCs)/ STILLBIRTH

Aliases

-

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

GENETIC AND HEREDITARY DISORDERS

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

15

TAT Units

DAYS

Test Requirements

NB: This test is very time sensitive with a high risk for failed karyotyping; preferred test is CHROMOSOMAL MICROARRAY, PRODUCTS OF CONCEPTION (POC)/ STILLBIRTH!!! Viable foetal tissue/ products of conception (POCs) in tissue culture media (or RPMI/ Hank's/ Ringer's lactate/ normal saline to which 3-4 drops of gentamicin have been added). Promptly deliver. Notify central lab in advance. First trimester loss: At least 10g chorionic villi/ POCs in culture media or normal saline with antibiotics. (3-4 drops of procaine penicillin or gentamicin). Second trimester and beyond: dual specimens preferred i.e. 1) placental biopsy from foetal side within 1 inch of the placental insertion site plus 2) foetal tissue (e.g. muscle biopsy from medial aspect of the thigh or foetal toe). Specimens to be submitted in culture media or normal saline with antibiotics. (3-4 drops of procaine penicillin or gentamicin).

Clinical Utility

Establishing causes of pregnancy losses & fetal abnormalities arising from detects numerical & structural chromosomal abnormalities within the assay's limit of detection.

Last Review

26th Feb 2026

HEPATITIS B QUALITATIVE PCR

Test Name

HEPATITIS B QUALITATIVE PCR

Aliases

HBV DNA QUALITATIVE PCR

Abbreviations

HBV PCR

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

INFECTIOUS

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

5

TAT Units

DAYS

Test Requirements

2-3 mL of serum or 2-3 mL of EDTA plasma. NB: Order MUST be clarified if the doctor simply states HBV PCR i.e. clarification on whether qualitative PCR should be done (used for DIAGNOSIS; code MP2313) or whether quantitative PCR/ viral load should be done (used for TREATMENT MONITORING where diagnosis is ALREADY established). If the order states viral load, this is synonymous with QUANTItative PCR and this code should NOT be selected. Instead code MP2310 should be selected. SHIPPING/ TRANSPORTATION REQUIREMENTS Shipping Temperature: Refrigerated ANALYTE STABILITY Room Temperature: 7 days at 20-25°C │ Refrigerated: 1 month at 2-8°C │ Frozen: 1 month at -20°C

Clinical Utility

o DIAGNOSE hepatitis B virus (HBV) infection e.g. in patients with inconclusive serology results. If detectable for more than 6 months, this is consistent with chronic HBV infection. It is NOT intended for treatment response monitoring.

Last Review

26th Feb 2026

JAK2 V617F MUTATION DETECTION

Test Name

JAK2 V617F MUTATION DETECTION

Aliases

-

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

ONCOLOGY

TAT Category

BUSINESS (WORKING) TIME

Estimated TAT

192

TAT Units

HOURS

Test Requirements

3-5 ml of EDTA whole blood is required or 3-5 ml of EDTA bone marrow, depending on clinical history.

Clinical Utility

Used in the diagnosis of myeloproliferative neoplasms (mpn), e.g., polycythemia vera, essential thrombocythemia.

Last Review

26th Feb 2026

SARS-CoV-2 PCR, QUALITATIVE

Test Name

SARS-CoV-2 PCR, QUALITATIVE

Aliases

-

Abbreviations

-

Test Classification

GROUPED TEST

Department

MOLECULAR PATHOLOGY

Sub Department

INFECTIOUS

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

7

TAT Units

DAYS

Test Requirements

Nasopharyngeal (NP) swab/ oropharyngeal (OP) swab in viral transport media (VTM).

Clinical Utility

Evaluation of COVID-19 disease/ infection

Last Review

26th Feb 2026

KARYOTYPING, BONE MARROW

Test Name

KARYOTYPING, BONE MARROW

Aliases

-

Abbreviations

-

Test Classification

INDIVIDUAL

Department

MOLECULAR PATHOLOGY

Sub Department

GENETIC AND HEREDITARY DISORDERS

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

16

TAT Units

DAYS

Test Requirements

Bone marrow in sodium heparin vacutainer. Clinical history/ indication required. Specific form to be filled before sending out.

Clinical Utility

Karyotyping bone marrow samples helps diagnose and/ or monitor and/ or prognosticate a variety of hematological disorders (leukemias, lymphomas, myelodysplastic syndromes) and guide cancer treatment by identifying specific chromosomal abnormalities. This cytogenetic analysis is essential for understanding genetic contributions to diseases and providing targeted medical care​. Detects numerical & structural chromosomal abnormalities within the assay's limit of detection. A normal result does not completely exclude genetic disorders e.g. single gene disorders, submicroscopic cytogenetic abnormalities below the assay's detection limit.

Last Review

26th Feb 2026

YELLOW FEVER PANEL

Test Name

YELLOW FEVER PANEL

Aliases

-

Abbreviations

-

Test Classification

GROUPED TEST

Department

MOLECULAR PATHOLOGY

Sub Department

INFECTIOUS

TAT Category

ELAPSED (CONTINUOUS) TIME

Estimated TAT

168

TAT Units

HOURS

Test Requirements

Serum in plain tube (red top) or SST tube (yellow top) or in a separation vial. Centrifuge tubes within 1 hour. Separate centrifuged serum in plain tubes within 1 hour. Test components: Yellow fever virus IgM, Yellow fever virus IgG, Yellow fever virus RNA (RT-PCR)

Clinical Utility

Diagnosis of yellow fever.

Last Review

26th Feb 2026